東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Drug interactions in infectious dise...

Pai, Manjunath P.

Linked to FindBook

Google Book

Amazon

博客來

Drug interactions in infectious diseases = antimicrobial drug interactions /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Drug interactions in infectious diseases/ edited by Manjunath P. Pai ... [et al.].
Reminder of title:	antimicrobial drug interactions /
other author:	Pai, Manjunath P.
Published:	Cham :Springer International Publishing : : 2018.,
Description:	xvi, 565 p. :ill., digital ;24 cm.
[NT 15003449]:	Beta-Lactam Antibiotics -- Macrolides, Azalides, and Ketolides -- Quinolones -- Glycopeptides, Lipopeptides, and Lipoglycopeptides -- Miscellaneous Antibiotics -- Drugs for Tuberculosis -- Drug Interactions in HIV: Protease and Integrase Inhibitors -- Drug Interactions in HIV: Nucleoside, Nucleotide, and Nonnucleoside Reverse Transcriptase Inhibitors and Entry Inhibitors -- Hepatitis B and Hepatitis C Antiviral Agents -- Drug Interactions of Non-HIV Antiviral Agents -- Antifungal Agents -- Antimalarial Agents -- Antiprotozoal and Anthelminthic Agents.
Contained By:	Springer eBooks
Subject:	Drug interactions. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-72416-4
ISBN:	9783319724164

Drug interactions in infectious diseases = antimicrobial drug interactions /
Drug interactions in infectious diseasesantimicrobial drug interactions /[electronic resource] :edited by Manjunath P. Pai ... [et al.]. - 4th ed. - Cham :Springer International Publishing :2018. - xvi, 565 p. :ill., digital ;24 cm. - Infectious disease. - Infectious disease..

Beta-Lactam Antibiotics -- Macrolides, Azalides, and Ketolides -- Quinolones -- Glycopeptides, Lipopeptides, and Lipoglycopeptides -- Miscellaneous Antibiotics -- Drugs for Tuberculosis -- Drug Interactions in HIV: Protease and Integrase Inhibitors -- Drug Interactions in HIV: Nucleoside, Nucleotide, and Nonnucleoside Reverse Transcriptase Inhibitors and Entry Inhibitors -- Hepatitis B and Hepatitis C Antiviral Agents -- Drug Interactions of Non-HIV Antiviral Agents -- Antifungal Agents -- Antimalarial Agents -- Antiprotozoal and Anthelminthic Agents.

The 4th edition of Drug Interactions in Infectious Diseases is being split into two separate volumes - "Mechanisms and Models of Drug Interactions" and "Antimicrobial Drug Interactions". This volume, "Antimicrobial Drug Interactions," delivers a quick clinical resource that distills relevant drug interactions by antimicrobial drug class. The book provides informative tables on specific drug-drug interactions that include the degree and severity of the expected interaction. A mechanistic basis for drug-drug interactions is also provided to link observed interactions to pharmacologic characteristics of key drug classes. This complete resource is organized by major antibacterial, antimycobacterial, antiviral, antifungal, antimalarial, and antiprotozoal class. In line with current innovations in antimicrobial drug development, a distinct chapter on the pharmacologic management of drug interactions in hepatitis B virus (HBV) and hepatitis C virus (HCV)-related infections is included. Two new chapters are dedicated to the management of human immunodeficiency virus (HIV) drug-drug interactions given the breadth of antiretroviral class-specific effects. This comprehensive review of known drug interactions and strategies to manage them is an invaluable resource to all health care practitioners.

ISBN: 9783319724164

Standard No.: 10.1007/978-3-319-72416-4doiSubjects--Topical Terms:

548667
Drug interactions.

LC Class. No.: RM302 / .D784 2018

Dewey Class. No.: 615.7045

Drug interactions in infectious diseases = antimicrobial drug interactions /
LDR:02893nmm a2200337 a 4500 001 2137150
003 DE-He213
005 20181012145517.0
006 m d
007 cr nn 008maaau
008 181117s2018 gw s 0 eng d
020 $a 9783319724164 $q (electronic bk.)
020 $a 9783319724157 $q (paper)
024 7 $a 10.1007/978-3-319-72416-4 $2 doi
035 $a 978-3-319-72416-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RM302 $b .D784 2018
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
082 0 4 $a 615.7045 $2 23
090 $a RM302 $b .D794 2018
245 0 0 $a Drug interactions in infectious diseases $h [electronic resource] : $b antimicrobial drug interactions / $c edited by Manjunath P. Pai ... [et al.].
250 $a 4th ed.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2018.
300 $a xvi, 565 p. : $b ill., digital ; $c 24 cm.
490 1 $a Infectious disease
505 0 $a Beta-Lactam Antibiotics -- Macrolides, Azalides, and Ketolides -- Quinolones -- Glycopeptides, Lipopeptides, and Lipoglycopeptides -- Miscellaneous Antibiotics -- Drugs for Tuberculosis -- Drug Interactions in HIV: Protease and Integrase Inhibitors -- Drug Interactions in HIV: Nucleoside, Nucleotide, and Nonnucleoside Reverse Transcriptase Inhibitors and Entry Inhibitors -- Hepatitis B and Hepatitis C Antiviral Agents -- Drug Interactions of Non-HIV Antiviral Agents -- Antifungal Agents -- Antimalarial Agents -- Antiprotozoal and Anthelminthic Agents.
520 $a The 4th edition of Drug Interactions in Infectious Diseases is being split into two separate volumes - "Mechanisms and Models of Drug Interactions" and "Antimicrobial Drug Interactions". This volume, "Antimicrobial Drug Interactions," delivers a quick clinical resource that distills relevant drug interactions by antimicrobial drug class. The book provides informative tables on specific drug-drug interactions that include the degree and severity of the expected interaction. A mechanistic basis for drug-drug interactions is also provided to link observed interactions to pharmacologic characteristics of key drug classes. This complete resource is organized by major antibacterial, antimycobacterial, antiviral, antifungal, antimalarial, and antiprotozoal class. In line with current innovations in antimicrobial drug development, a distinct chapter on the pharmacologic management of drug interactions in hepatitis B virus (HBV) and hepatitis C virus (HCV)-related infections is included. Two new chapters are dedicated to the management of human immunodeficiency virus (HIV) drug-drug interactions given the breadth of antiretroviral class-specific effects. This comprehensive review of known drug interactions and strategies to manage them is an invaluable resource to all health care practitioners.
650 0 $a Drug interactions. $3 548667
650 0 $a Anti-infective agents. $3 634368
650 0 $a Communicable diseases. $3 669516
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Pharmaceutical Sciences/Technology. $3 1001579
650 2 4 $a Infectious Diseases. $3 894100
650 2 4 $a Pharmacy. $3 636101
700 1 $a Pai, Manjunath P. $3 3309207
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Infectious disease. $3 1566974
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-72416-4
950 $a Medicine (Springer-11650)